BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25516667)

  • 41. Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis?: a prospective study.
    Parente F; Molteni M; Marino B; Colli A; Ardizzone S; Greco S; Sampietro G; Foschi D; Gallus S
    Am J Gastroenterol; 2010 May; 105(5):1150-7. PubMed ID: 19997096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Epidemiology and clinical characteristics of ulcerative colitis in north-eastern Mexico].
    Bosques-Padilla FJ; Sandoval-García ER; Martínez-Vázquez MA; Garza-González E; Maldonado-Garza HJ
    Rev Gastroenterol Mex; 2011; 76(1):34-8. PubMed ID: 21592901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ulcerative colitis in northern Portugal and Galicia in Spain.
    Barreiro-de Acosta M; Magro F; Carpio D; Lago P; Echarri A; Cotter J; Pereira S; Gonçalves R; Lorenzo A; Carvalho L; Castro J; Barros L; Dias JA; Rodrigues S; Portela F; Dias C; da Costa-Pereira A; ;
    Inflamm Bowel Dis; 2010 Jul; 16(7):1227-38. PubMed ID: 19924807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients.
    Wang Y; Ouyang Q;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1450-5. PubMed ID: 17716349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decision tree for early introduction of rescue therapy in active ulcerative colitis treated with steroids.
    Mañosa M; Cabré E; Garcia-Planella E; Bernal I; Gordillo J; Esteve M; Zabana Y; Gassull MA; Domènech E
    Inflamm Bowel Dis; 2011 Dec; 17(12):2497-502. PubMed ID: 21472824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beverage Consumption and Ulcerative Colitis: A Case-Control Study from Saudi Arabia.
    Almofarreh A; Sheerah HA; Arafa A; Ahamed SS; Alzeer O; Al-Hunaishi W; Mhimed MM; Al-Hazmi A; Lim SH
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of the Montreal classification for inflammatory bowel diseases.
    Spekhorst LM; Visschedijk MC; Alberts R; Festen EA; van der Wouden EJ; Dijkstra G; Weersma RK;
    World J Gastroenterol; 2014 Nov; 20(41):15374-81. PubMed ID: 25386087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).
    Solberg IC; Lygren I; Jahnsen J; Aadland E; Høie O; Cvancarova M; Bernklev T; Henriksen M; Sauar J; Vatn MH; Moum B;
    Scand J Gastroenterol; 2009; 44(4):431-40. PubMed ID: 19101844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammatory bowel disease. An epidemiological and genetic study.
    Monsén U
    Acta Chir Scand Suppl; 1990; 559():1-42. PubMed ID: 2092567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
    Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis.
    Lee HJ; Jung ES; Lee JH; Hong SP; Kim TI; Kim WH; Cheon JH
    Hepatogastroenterology; 2012; 59(117):1415-20. PubMed ID: 22683958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relapse rates of ulcerative colitis in remission and factors related to relapse].
    Park BJ; Lee KJ; Hwang JC; Sin SJ; Chung JY; Cho SW
    Korean J Gastroenterol; 2008 Jul; 52(1):21-6. PubMed ID: 19077487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.
    Cañas-Ventura A; Márquez L; Ricart E; Domènech E; Gisbert JP; García-Sanchez V; Marín-Jiménez I; Rodriguez-Moranta F; Gomollón F; Calvet X; Merino O; Garcia-Planella E; Vázquez-Romero N; Esteve M; Iborra M; Gutiérrez A; Vera M; Andreu M;
    J Crohns Colitis; 2014 Oct; 8(10):1287-93. PubMed ID: 24726696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-reported frequency and severity of disease flares, disease perception, and flare treatments in patients with ulcerative colitis: results of a national internet-based survey.
    Bolge SC; Waters H; Piech CT
    Clin Ther; 2010 Feb; 32(2):238-45. PubMed ID: 20206781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older?
    Lee JH; Cheon JH; Moon CM; Park JJ; Hong SP; Kim TI; Kim WH
    Digestion; 2010; 81(4):237-43. PubMed ID: 20110709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma viscosity: a potential predictor of both medical treatment response and clinical stage of ulcerative colitis.
    Yakar T; Cosar AM; Gokturk HS; Kanat UG; Parlakgumus A; Kozanoglu I; Serin E
    Ann Ital Chir; 2016; 87():531-543. PubMed ID: 28070034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.
    Herrinton LJ; Liu L; Fireman B; Lewis JD; Allison JE; Flowers N; Hutfless S; Velayos FS; Abramson O; Altschuler A; Perry GS
    Gastroenterology; 2009 Aug; 137(2):502-11. PubMed ID: 19445944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutaneous manifestations in inflammatory bowel disease.
    Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
    Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.